How many email patterns does Oragenics, Inc use?

Oragenics, Inc uses 3 known email patterns.

What domain does Oragenics, Inc use for work emails?

Oragenics, Inc uses oragenics.com for work email addresses.

Most Common Email Formats at Oragenics, Inc

The most accurate and popular Oragenics, Inc's email format is FLast@oragenics.com (ex. JDoe@oragenics.com). Oragenics, Inc also uses Last@oragenics.com (ex. Doe@oragenics.com) as email structures. Oragenics, Inc uses up to 3 different email patterns.

Oragenics, Inc Email Formats	Example	Percentage
FLast@oragenics.com	JDoe@oragenics.com	94%
Last@oragenics.com	Doe@oragenics.com	3%
LFirst@oragenics.com	DJohn@oragenics.com	3%

Oragenics, Inc Email Formats

Example

Percentage

FLast@oragenics.com

JDoe@oragenics.com

94%

Last@oragenics.com

Doe@oragenics.com

LFirst@oragenics.com

DJohn@oragenics.com

Frequently Asked Questions

What does Oragenics, Inc do?

operates in the Biotechnology Research industry, along with similar companies like SanofiUnileverJohnson & Johnson. You can visit oragenics.comcontact Oragenics, Inc's headquarters by phone at

+1-813-286-****

. Explore Oragenics, Inc's company overview page for more information.

What is Oragenics, Inc's email address format?

Oragenics, Inc's email format typically follows the pattern of FLast@oragenics.com; this email format is used 94% of the time. Other contacts within LeadIQ's database had email formats such as Last@oragenics.comLFirst@oragenics.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Oragenics, Inc have currently?

Oragenics, Inc has approximately 18 employees as of July 2026. Key team members to contact include Chief Financial Officer Treasurer Secretary: J. H.Gerente General: I. E.. For more team information and contact data, explore Oragenics, Inc's employee directory with LeadIQ.

Oragenics, Inc Email Format

Biotechnology ResearchFlorida, United States11-50 Employees

Oragenics, Inc. is a development-stage biotechnology company based in Tampa, Florida, focused on infectious diseases and neurological conditions. Its lead program, NT-CoV2-1, is an intranasal vaccine candidate intended to prevent COVID-19 and SARS-CoV-2 variants, built on spike protein research licensed from the NIH and NRC with a focus on reducing transmission and patient-friendly administration. The company also pursues a lantibiotics program targeting bacteria that have developed resistance to conventional antibiotics. In May 2026 it announced a letter of intent to license CardioDialysis technology from Sigyn Therapeutics for traumatic brain injury and related chronic neurodegenerative diseases.

Oragenics' activities target clinical researchers and healthcare providers seeking new intranasal therapeutics and neuroprotective strategies. Its ONP-002 intranasal neurosteroid for concussion and mild traumatic brain injury is in Phase IIa trials, and the company has been pursuing IND readiness collaborations and Australian site onboarding to advance its programs.

Most Common Email Formats at Oragenics, Inc

Frequently Asked Questions

What does Oragenics, Inc do?

What is Oragenics, Inc's email address format?

How many employees does Oragenics, Inc have currently?

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

Oragenics, Inc Email Format

Verify Oragenics, Inc email addresses

Ready to create more pipeline?

Ready to create more pipeline?

Most Common Email Formats at Oragenics, Inc

Frequently Asked Questions

What does Oragenics, Inc do?

What is Oragenics, Inc's email address format?

How many employees does Oragenics, Inc have currently?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Oragenics, Inc Email Format

Verify Oragenics, Inc email addresses

Ready to create more pipeline?

Ready to create more pipeline?

Everything for prospecting,
in one platform.